Founders Bank & Trust »

GlaxoSmithKline shares owned by Founders Bank & Trust

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Founders Bank & Trust from 13F filings

Historical chart of Founders Bank & Trust investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Founders Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Founders Bank & Trust

Quarter filed Position value Share count Share price at filing
2013-03-31 $41k 870 47.13
2012-12-31 $27k 620 43.55
2011-09-30 $17k 400 42.50

More positions owned by Founders Bank & Trust

iShares S&P 500 Index (IVV)
PIMCO Enhanced Short Mat Str Fund ETF (MINT)
Spdr S&p 500 Etf (SPY)
Vanguard FTSE All-World ex-US ETF (VEU)
iShares Russell 1000 Value Index (IWD)
Vanguard Dividend Appreciation ETF (VIG)
Vanguard High Dividend Yield ETF (VYM)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
SPDR S&P International Dividend (DWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Short Term Corporate Bond ETF (VCSH)
First Trust Morningstar Divid Ledr (FDL)
Ishares High Dividend Equity F (HDV)
iShares Dow Jones Select Dividend (DVY)
Pepsi (PEP)

View all positions for Founders Bank & Trust

Top funds holding GlaxoSmithKline

Columbia Asset Management
Paradigm Asset Management Company
Accent Capital Management
Park Circle
Byrne Asset Management
Retirement Group
Huntington National Bank

View all funds holding GlaxoSmithKline